Twist Bioscience (TWST) Non-Current Debt (2018 - 2026)

Twist Bioscience (TWST) has reported Non-Current Debt for 6 consecutive years, with $15.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Debt changed 0.0% year-over-year to $15.0 million in Q2 2026; TTM through Jun 2026 was $15.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $15.0 million, changed N/A from the prior year.
• Non-Current Debt was $15.0 million for Q2 2026 at Twist Bioscience, roughly flat from $15.0 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $15.0 million in Q4 2024 and troughed at $15.0 million in Q4 2024.
• A 3-year average of $15.0 million and a median of $15.0 million in 2024 frame the typical range for Non-Current Debt.
• The widest YoY moves for Non-Current Debt: up 0.0% in 2025, down 0.0% in 2025.
• Over 3 years, Non-Current Debt stood at $15.0 million in 2024, then changed by 0.0% to $15.0 million in 2025, then changed by 0.0% to $15.0 million in 2026.
• The last three Non-Current Debt figures came in at $15.0 million (Q2 2026), $15.0 million (Q1 2026), and $15.0 million (Q4 2025), per Business Quant data.